investorscraft@gmail.com

Stock Analysis & ValuationZhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS)

Professional Stock Screener
Previous Close
$9.87
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)27.95183
Intrinsic value (DCF)4.34-56
Graham-Dodd Method2.47-75
Graham Formula1.41-86

Company Information

No. 5 Donghai Fourth Lane
Linhai 317016
China
Phone: 86 576 8558 9335
Industry: Biotechnology
Sector: Healthcare
CEO: Zhiguo Zheng
Full Time Employees: 1174

Zhejiang Ausun Pharmaceutical Co., Ltd. develops, produces, and sells specialty drug substances and pharmaceutical intermediates. It offers fluorine products, prostaglandins, antimicrobials, and oncology products. The company also provides products for liver disease, respiratory system, and cardiac and cerebral vessels, as well as CNS indications. In addition, it is involved in the processing, and research and development business. The company was founded in 2010 is based in Linhai, China.

HomeMenuAccount